Dodolan perusahaan alxoncology.com (ALXO)

ALX Oncology Holdings Inc. - logo grafis emiten ALXO

ALX Oncology Holdings (ALXO) relies on California-based laboratories and external CDMO partners for protein production. The company's sales structure and volume demonstrate that the 0.00 level is a current figure, although commercial revenue is absent due to the development stage. Primary risks are concentrated on drug safety and potential failures during clinical trials of new therapy methods.

alxoncology.com (ALXO): Pendapatan perusahaan saka 04.07.2022 nganti 18.11.2026

Rincian analitis perusahaan alxoncology.com (ALXO)

- nilai saham lan prakiraan konsensus rega:
Analisis umum perusahaan:ALX Oncology, ALXO
Produk asli ALX Oncology Holdings

The current sales volume of ALX Oncology Holdings (ALXO) reflects the commercialization potential of the innovative CD47 blocker evopsorestat in oncology therapy. This indicator captures actual cash flow from operating activities, confirming the execution of strategic business plans. The calculation is based on the summation of daily receipts, allowing for the prompt identification of cash gaps and the assessment of resource liquidity. Steady growth in this metric minimizes capital impairment risks and confirms the fundamental stability of the issuer.

Pesaing wigati

Dodolan perusahaan immunitybio.com (IBRX)|Pendapatan perusahaan Immunocore Holdings (IMCR)|Dodolan perusahaan Janux Pharma JANX|Arcus Biosciences Inc - Dodolan perusahaan|Pendapatan lan volume dodolan Zymeworks Biopharmaceuticals ZYME|TNGX - Pendapatan perusahaan|IOVA (iovance.com) - Volume dodolan perusahaan|Immatics Biotechnologies (IMTX) - Pendapatan perusahaan|Total pendapatan perusahaan Xencor Corp (XNCR)|Dodolan perusahaan CMPX|REPL - Total volume dodolan perusahaan|Dodolan perusahaan LYEL (Lyell Immunopharma Inc)|Total dodolan perusahaan IPHA|Pendapatan lan volume dodolan PYXS (Pyxis Oncology, Inc.)|Pendapatan dodolan perusahaan CGEN|iobiotech.com - Pendapatan lan volume dodolan|Total pendapatan perusahaan Sutro Biopharma, Inc|MiNK Therapeutics, Inc. (INKT) - Pendapatan perusahaan|Werewolf Therapeutics Inc. - Pendapatan dodolan perusahaan|IMMX (Immix) - Pendapatan lan volume dodolan|Cue Biopharma, Inc. - Pendapatan tahunan perusahaan|Pendapatan perusahaan pdsbiotech.com (PDSB)|SONN: Pendapatan tahunan perusahaan|MAIA Biotech - Dodolan perusahaan|liminatuspharma.com (LIMN) - Total pendapatan perusahaan|LVTX - Pendapatan perusahaan|NXTC (NextCure) - Volume dodolan perusahaan|LPTX: Pendapatan lan volume dodolan|Volume dodolan perusahaan INTS|Pendapatan perusahaan Sensei Biotherapeutics, Inc.|Total pendapatan perusahaan therivabio.com TOVX|Dodolan perusahaan GRTS (Gritstone bio, Inc.)|Pendapatan lan volume dodolan Kineta Bio (KA)|Pendapatan perusahaan NexImmune Corporation NEXI|Pendapatan reged perusahaan turnstonebio.com (TSBX)|VCNX - Pendapatan perusahaan|Total pendapatan perusahaan harpoontx.com